Materna Medical

Materna Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $12.2M

Overview

Materna Medical is a private, venture-backed medical device company founded in 2015, targeting the large and underserved women's pelvic health market. The company has commercialized its first product, the Milli Vaginal Dilator, and is conducting a pivotal clinical trial for its second product, the Ellora System, designed for labor and delivery. Led by an experienced team of MedTech executives and clinicians, Materna is building a platform company to transform the standard of care in OBGYN.

Women's HealthPelvic HealthObstetrics

Technology Platform

Precision incremental mechanical dilation platform adaptable for pelvic floor rehabilitation and obstetric care.

Funding History

2
Total raised:$12.2M
Series A$9M
Seed$3.2M

Opportunities

The $25B women's pelvic health market is vastly underserved, with high demand for modern, effective solutions.
A successful Ellora System could redefine standard of care in labor & delivery, addressing a universal healthcare event.
The direct-to-consumer model for Milli taps into the growing, scalable femtech e-commerce segment.

Risk Factors

The company's value is highly dependent on the success of the Ellora System's pivotal trial, which carries clinical, regulatory, and execution risk.
Commercial adoption in hospitals for Ellora faces significant hurdles in changing clinical practice and securing reimbursement.
The femtech/DTC space for Milli is becoming increasingly competitive.

Competitive Landscape

For vaginismus treatment, Milli competes with traditional static dilators and a small number of other vibrating dilators, but its incremental expansion is a key differentiator. In the labor & delivery space, the Ellora System appears novel; direct competitors for mechanical cervical/vaginal preparation are limited, but it must displace entrenched manual techniques and compete for attention with other labor management tools and pharmaceuticals.